Brief: Gracell Biotechnologies Reports Qtrly Loss Per Share $0.07
16/05/2022 13:37
May 16 (Reuters) - Gracell Biotechnologies Inc GRCL.O :
* GRACELL BIOTECHNOLOGIES REPORTS FIRST QUARTER 2022
UNAUDITED
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* GRACELL BIOTECHNOLOGIES INC - QTRLY LOSS PER SHARE $0.07
Source text for Eikon: ID:nGNX1z7Vsc
Further company coverage: GRCL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gracell Biotechnologies
See all newsBrief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement
Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing
Live Markets: European futures rise after holiday break
Press Digest: British Business - Dec 27